@misc{cogprints4191,
          volume = {4},
          number = {3},
           month = {July},
          author = {Martijn A Oudijk and Gerard HA Visser and Erik J Meijboom},
          editor = {Balbir Singh and Yash Lokhandwala and Johnson Francis and Anup Gupta},
           title = {Fetal Tachyarrhythmia - Part I: Diagnosis },
       publisher = {Indian Pacing and Electrophysiology Group},
            year = {2004},
         journal = {Indian Pacing and Electrophysiology Journal},
           pages = {104--113},
        keywords = {Fetal tachyarhythmia; fetal echocardiography; fetal magnetocardiography},
             url = {http://cogprints.org/4191/},
        abstract = {Fetal tachycardia, first recognized in 1930 by Hyman et al1, is a condition occurring in approximately 0.4-0.6\% of all pregnancies2. A subset of these cases with more sustained periods of tachycardia is clinically relevant. The necessity of therapeutic intervention in this condition is still a matter of discussion focused on the natural history of the disease. The spectrum of opinions varies from non-intervention3,4,5 based on a number of cases in which the tachycardia subsided spontaneously6, to aggressive pharmacotherapeutic intervention7,8 based on reports of deterioration of the fetal condition ultimately ending in significant neurological morbidity9,10,11, or fetal demise12,13,14. Prenatal treatment through indirect, maternally administered drug therapy seems to be the preference of most centers15,16,17,18,19,20,21. This matter will be discussed further in Fetal Tachyarrhythmia, Part II, Treatment. }
}

<script src="//archive-bar.soton.ac.uk/archive-bar.js"></script>